Inotek (ITEK) Surges on Peer's Trial Failure
Tweet Send to a Friend
Inotek Pharmaceuticals (NASDAQ: ITEK) is gaining sharply early in early trading Friday (+19%) with analysts pointing to Aerie Pharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


